New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
Peptides Are Having a Moment (Peptides, Part 1)
Consulting with healthcare providerssuch as pediatricians, dietitians, or specialistsis critical to creating effective and safe nutrition strategies
Recognizing these patterns is key to identifying at-risk patients, anticipating complications, and guiding safe management
Additionally, Exe4 has been shown to be less effective in reducing body weight in leptin-deficient ob / ob mice, highlighting the need for further evaluation in diverse obesity models 40
With 1.5 million people across the UK using a GLP-1 medication as of March 2025